Loading data
BIVINasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Research and development expense | 13.96 m USD | 9.27 m USD | 23.1 m USD | 33.3 m USD | 17.26 m USD |
| Selling, general and administrative expense | — | 8.57 m USD | 8.85 m USD | 11.55 m USD | 9.77 m USD |
| Operating profit | -22.65 m USD | -18.07 m USD | -32.18 m USD | -45.08 m USD | -27.25 m USD |
| Interest expense | 17.9 k USD | 332.72 k USD | 2.89 m USD | 4.3 m USD | 2.16 m USD |
| Net income (reported basis) | -22.07 m USD | -17.54 m USD | -32.12 m USD | -50.26 m USD | -26.08 m USD |
| Net income attributable to common shareholders | — | — | -33.01 m USD | -50.26 m USD | -26.08 m USD |
| Basic earnings per share | -3.05 USD/share | -12.12 USD/share | -73.05 USD/share | -15.47 USD/share | -1.06 USD/share |
| Diluted earnings per share | -3.05 USD/share | -12.12 USD/share | -73.05 USD/share | -15.47 USD/share | -1.06 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.